Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001641172-25-005313
Filing Date
2025-04-17
Accepted
2025-04-17 17:28:24
Documents
17
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 91208
2 ex23-2.htm EX-23.2 4094
3 ex31-1.htm EX-31.1 14185
4 ex31-2.htm EX-31.2 14698
  Complete submission text file 0001641172-25-005313.txt   612342

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mira-20241231.xsd EX-101.SCH 17716
6 XBRL DEFINITION FILE mira-20241231_def.xml EX-101.DEF 6261
7 XBRL LABEL FILE mira-20241231_lab.xml EX-101.LAB 137903
8 XBRL PRESENTATION FILE mira-20241231_pre.xml EX-101.PRE 72749
19 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 8106
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
Type: 10-K/A | Act: 34 | File No.: 001-41765 | Film No.: 25848552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)